| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
xiv |
| issn |
0889-8588 |
| issueIdentifier |
5 |
| pageRange |
xiii-xiv |
| publicationName |
Hematology/Oncology Clinics of North America |
| startingPage |
xiii |
| bibliographicCitation |
Leonard JP. Mantle Cell Lymphoma: Biologic Insights to Bedside Impact. Hematology/Oncology Clinics of North America. 2020 Oct;34(5):xiii–xiv. doi: 10.1016/j.hoc.2020.07.001. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_191f9f901622232de240d4cd0276f4df |
| date |
202010 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/32861292
https://doi.org/10.1016/j.hoc.2020.07.001 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0889-8588
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4513 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Mantle Cell Lymphoma: Biologic Insights to Bedside Impact |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D020522Q000628
http://id.nlm.nih.gov/mesh/D020522Q000473
http://id.nlm.nih.gov/mesh/D020522Q000378 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D011173
http://id.nlm.nih.gov/mesh/D006801 |